Evolution of the Average Target: Exact Sciences Corporation

Evolution of the Target Price: Exact Sciences Corporation

Changes in Analyst Recommendations: Exact Sciences Corporation

c8.wQXlKFj6jEWifwyuNIlKhS92_yuTR5iPd0CMwBROTrE.-W7WTj-Y2HXKG0HAWsYl8xwvnUr3Iev8ACL-uCIUf9KYMZ9KDqnoCegJbw~c6b3d194225d89b0d93a0b01451cb241
RBC Raises Price Target on Exact Sciences to $54 From $52, Keeps Sector Perform Rating May. 02 MT
Mizuho Initiates Exact Sciences at Outperform With $60 Price Target Apr. 10 MT
Analyst recommendations: Illumina, Boeing, Next, Walmart, Applovin.... Mar. 28Our Logo
RBC Initiates Exact Sciences at Sector Perform With $52 Price Target Mar. 13 MT
Barclays Initiates Exact Sciences at Overweight Jan. 23 MT
BTIG Raises Price Target on Exact Sciences to $75 From $65, Maintains Buy Rating Nov. 26 MT
Analyst recommendations: Snap, Qualys, Sirius XM, Super Micro Computer, Burberry... Nov. 06Our Logo
Analyst recommendations: 3M Company, GM, IBM, Robinhood, Moonpig... 24-10-29Our Logo
Wells Fargo Global Initiates Exact Sciences at Overweight With $75 Price Target 24-08-28 MT
UBS Cuts Exact Sciences' Price Target to $61 From $66, Maintains Neutral Rating 24-08-01 MT
Scotiabank Initiates Exact Sciences at Sector Outperform With $70 Price Target 24-06-27 MT
BTIG Lowers Price Target on Exact Sciences to $70 From $80, Maintains Buy Rating 24-06-26 MT
Benchmark Upgrades Exact Sciences to Buy From Hold, Sets Price Target at $91 24-01-02 MT
Goldman Sachs Adjusts Price Target on Exact Sciences to $90 From $100, Keeps Buy Rating 23-11-03 MT
BofA Securities Cuts Price Target on Exact Sciences to $88 From $110, Maintains Buy Rating 23-10-20 MT
Piper Sandler Upgrades Exact Sciences to Overweight From Neutral, Price Target is $90 23-10-10 MT
Bernstein Starts Exact Sciences With Outperform Rating 23-09-28 MT
Baird Adjusts Price Target on Exact Sciences to $121 From $99, Maintains Outperform Rating 23-08-02 MT
Benchmark Downgrades Exact Sciences to Hold From Buy 23-08-02 MT
Credit Suisse Adjusts Exact Sciences' Price Target to $90 From $75, Keeps Neutral Rating 23-08-02 MT
Goldman Sachs Adjusts Price Target on Exact Sciences to $110 From $85, Maintains Buy Rating 23-07-21 MT
UBS Raises Exact Sciences' Price Target to $99 From $73, Maintains Neutral Rating 23-06-27 MT
Canaccord Genuity Raises Price Target on Exact Sciences to $115 From $92, Maintains Buy Rating 23-06-23 MT
Analyst recommendations: BAE Systems, Berkeley, Burberry, Reinsurance Group, Tesla... 23-06-23Our Logo
Citigroup Adjusts Price Target on Exact Sciences to $130 From $100, Keeps Buy Rating 23-06-22 MT
More recommendations

Consensus (Composite) Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Ecart obj. / dr
+32.03%
- - +5.2%
+48.94%
+0.31%
+45.48%
- +33.33%
+472.19%
+85.44%
Average +90.37%
Weighted average by Cap. +43.26%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
51.91USD
Average target price
68.54USD
Spread / Average Target
+32.03%
High Price Target
90.00USD
Spread / Highest target
+73.38%
Low Price Target
54.00USD
Spread / Lowest Target
+4.03%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

RBC Capital Markets
Mizuho Securities
Barclays
BTIG
Benchmark Company
Goldman Sachs
BofA Securities
Piper Sandler
Bernstein
Baird
Credit Suisse
UBS
Canaccord Genuity
Citigroup
Jefferies & Co.
Craig-Hallum
Cowen
Morningstar
Raymond James
SVB Securities LLC
Evercore ISI
SVB Leerink
Wells Fargo Securities
Oppenheimer
Truist Securities
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. EXAS Stock
  4. Consensus Exact Sciences Corporation